These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10150224)

  • 1. Surrogate end-points: the case of trials on coronary atherosclerotic plaque regression.
    Marchioli R; Prieto JC; Tognoni G
    Clin Trials Metaanal; 1994 Oct; 29(2-3):139-76. PubMed ID: 10150224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is regression of atherosclerosis possible?].
    Thomas D; Richard JL; Emmerich J; Bruckert E; Delahaye F
    Arch Mal Coeur Vaiss; 1992 Oct; 85 Spec No 3():47-57. PubMed ID: 1296545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of calcium antagonists on atherosclerosis progression and intima media thickness].
    Zannad F
    Drugs; 2000; 59 Spec No 2():39-46. PubMed ID: 11002857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive devices in primary or rescue PCI: a meta-analysis of randomized trials.
    Burzotta F; Testa L; Giannico F; Biondi-Zoccai GG; Trani C; Romagnoli E; Mazzari M; Mongiardo R; Siviglia M; Niccoli G; De Vita M; Porto I; Schiavoni G; Crea F
    Int J Cardiol; 2008 Jan; 123(3):313-21. PubMed ID: 17383756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
    Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW
    Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions that beneficially influence the evolution of coronary atherosclerosis. The case for calcium channel blockers.
    Waters D; Lespérance J
    Circulation; 1992 Dec; 86(6 Suppl):III111-6. PubMed ID: 1424044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary heart disease prevention and the infarctogenic plaque.
    Lewis B
    Isr J Med Sci; 1996 Jun; 32(6):360-3. PubMed ID: 8682641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regression of coronary atherosclerosis: possible--and clinically relevant?].
    Niederhauser HU
    Schweiz Rundsch Med Prax; 1991 Sep; 80(39):1019-23. PubMed ID: 1925225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials.
    Brener SJ; Ivanc TB; Poliszczuk R; Chen M; Tuzcu EM; Hu T; Frid DJ; Nissen SE
    Am Heart J; 2006 Dec; 152(6):1059-63. PubMed ID: 17161053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease.
    Nikolsky E; Lansky AJ; Sudhir K; Doostzadeh J; Cutlip DE; Piana R; Su X; White R; Simonton CA; Stone GW
    Am Heart J; 2009 Oct; 158(4):520-526.e2. PubMed ID: 19781409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
    Mercado N; Wijns W; Serruys PW; Sigwart U; Flather MD; Stables RH; O'Neill WW; Rodriguez A; Lemos PA; Hueb WA; Gersh BJ; Booth J; Boersma E
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):512-9. PubMed ID: 16077421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies.
    Opie LH; Yusuf S; Kübler W
    Prog Cardiovasc Dis; 2000; 43(2):171-96. PubMed ID: 11014332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
    Nissen SE
    Am J Cardiol; 2005 Sep; 96(5A):61F-68F. PubMed ID: 16126025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424.
    Boden WE; O'rourke RA; Teo KK; Hartigan PM; Maron DJ; Kostuk W; Knudtson M; Dada M; Casperson P; Harris CL; Spertus JA; Shaw L; Chaitman BR; Mancini GB; Berman DS; Weintraub WS;
    Am Heart J; 2006 Jun; 151(6):1173-9. PubMed ID: 16781214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive detection of subclinical coronary atherosclerosis coupled with assessment of changes in plaque characteristics using novel invasive imaging modalities: the Integrated Biomarker and Imaging Study (IBIS).
    Van Mieghem CA; McFadden EP; de Feyter PJ; Bruining N; Schaar JA; Mollet NR; Cademartiri F; Goedhart D; de Winter S; Granillo GR; Valgimigli M; Mastik F; van der Steen AF; van der Giessen WJ; Sianos G; Backx B; Morel MA; van Es GA; Zalewski A; Serruys PW
    J Am Coll Cardiol; 2006 Mar; 47(6):1134-42. PubMed ID: 16545642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials.
    De Luca G; Suryapranata H; Stone GW; Antoniucci D; Biondi-Zoccai G; Kastrati A; Chiariello M; Marino P
    Int J Cardiol; 2008 May; 126(1):37-44. PubMed ID: 17544528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.